Keywords:
COVID-19, надпочечник, иммуногистохимия, корковое вещество, экспрессия.References
1. Newman P.J. The biology of PECAM-1 // Journal of Clinical Investigation. – 1997. – Vol. 99, № 1. – P. 3–8.
2. Privratsky J.R., Newman P.J. PECAM-1: regulator of endothelial junctional integrity // Current Opinion in Hematology. – 2014. – Vol. 21, № 3. – P. 241–247.
3. Pusztaszeri M.P., Seelentag W., Bosman F.T. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor // Journal of Histochemistry & Cytochemistry. – 2006. – Vol. 54, № 4. – P. 385–395.
4. Varga Z., Flammer A.J., Steiger P. et al. Endothelial cell infection and endotheliitis in COVID-19 // The Lancet. – 2020. – Vol. 395, № 10234. – P. 1417–1418.
5. Ackermann M., Verleden S.E., Kuehnel M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19 // New England Journal of Medicine. – 2020. – Vol. 383. – P. 120–128.
6. Libby P., Lüscher T. COVID-19 is, in the end, an endothelial disease // European Heart Journal. – 2020. – Vol. 41, № 32. – P. 3038–3044.
7. Santana M.F., Borba M.G.S., Baía-da-Silva D.C. et al. Case report: Adrenal pathology findings in severe COVID-19: an autopsy study // Journal of Endocrinological Investigation. – 2021. – Vol. 44. – P. 459–464.
8. Zinserling V.A., Semenova N.Y., Markov A.G. et al. Inflammatory cell infiltration of adrenals in COVID-19 // Virchows Archiv. – 2020. – Vol. 477. – P. 773–775.
9. Kanczkowski W., Evert K., Stadtmüller M. et al. COVID-19 targets human adrenal glands // The Lancet Diabetes & Endocrinology. – 2022. – Vol. 10, № 1. – P. 13–16.
10. Тодоров С. С., Тодоров С. С., Казьмин А. С. Экспрессия белков cd31, фактора виллебранда в разные сроки covid-19 пневмонии // Вестник ВолГМУ. 2022. №3. URL: https://cyberleninka.ru/ article/n/ekspressiya-belkov-cd31-faktora-ville-branda-v-raznye-sroki-covid-19-pnevmonii (дата обращения: 18.02.2026).
